Aterian, Inc. 8-K

What Happened

• On April 27, 2026 Aterian, Inc. filed an 8‑K disclosing two related transactions. Aterian entered an Asset Purchase Agreement to sell specified assets tied to marquee brands (Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions and Photo Paper Direct) to Trademark Global for $18 million in cash, subject to purchase price adjustments and closing conditions.
• The company also entered a Securities Purchase Agreement with investor David E. Lazar: Lazar paid $2.00 per share to acquire 1,750,000 Series AA preferred shares (closed April 27, 2026) and agreed to buy 1,750,000 Series AAA preferred shares (second closing contingent on stockholder approvals) for aggregate gross proceeds of $7.0 million. Lazar was immediately appointed to the Board and will become CEO promptly following the Second SPA Closing.

Key Details

• Asset Sale price: $18 million cash (subject to adjustments); APA closing conditions include stockholder approval and contribution margins at least 87.5% of projected margins for certain periods. APA is not conditioned on financing.
• Financing: $7.0 million total — 1,750,000 Series AA shares (closed) and 1,750,000 Series AAA shares (pending). Series AA converts to 7.7 common shares each; Series AAA converts to between 117.63 and 135.10 common shares each depending on fully diluted capitalization at closing.
• Ownership after Second SPA Closing (if completed): Lazar ~95.13% and existing equityholders ~4.87% of fully‑diluted capitalization.
• Governance and approvals: Company must call a special stockholder meeting (targeted no later than July 20, 2026) to approve issuance of common shares upon conversion, increase authorized common shares (500M → up to 1,000M), election of four Lazar designees to the Board, and a potential reverse stock split (range 1‑for‑2 to 1‑for‑99). Company directors and officers entered a Voting Agreement committing to vote in favor of Board‑recommended proposals.
• Other contract terms: Certain assets/liabilities are excluded from the Asset Sale (e.g., cash, certain IP, certain Amazon accounts, benefit plans, certain tax assets/liabilities). Either party may terminate under specified conditions; termination payments could include a $1,080,000 break fee and up to $600,000 reimbursement of Trademark Global’s transaction expenses.
• Securities sale relied on Regulation S (private, non‑U.S. offers); securities were not registered under the U.S. Securities Act.

Why It Matters

• The transactions materially reshape Aterian’s business and capital structure: the $18M asset sale transfers several of Aterian’s marquee brands away from the company, while the $7M preferred-stock financing brings in David Lazar as a controlling investor and board member (and future CEO upon closing).
• If the Second SPA Closing and related approvals occur, Lazar would control roughly 95% of the company on a fully‑diluted basis, driving major governance changes (new Board members, CEO change) and potential equity actions (authorized share increase, reverse split) that will significantly affect existing shareholders’ ownership and the company’s strategic direction.
• These transactions are subject to stockholder approvals and other closing conditions and are not final until those conditions are satisfied. Aterian says it will continue to operate smaller legacy brands (e.g., Vremi, Xtava) after the Asset Sale.